Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor

Trial Profile

Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jan 2018

At a glance

  • Drugs Ivacaftor (Primary)
  • Indications Cystic fibrosis
  • Focus Therapeutic Use
  • Acronyms G551D
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 08 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top